Propanc Biopharma, Inc. (PPCB)
0.5575
-0.03
(-4.83%)
USD |
NASDAQ |
Dec 29, 16:00
0.55
-0.01
(-1.35%)
After-Hours: 20:00
Propanc Biopharma Market Cap: 7.450M for Dec. 29, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Lumos Diagnostics Holdings Ltd. | 149.45M |
| Incannex Healthcare, Inc. | 126.82M |
| NovaBay Pharmaceuticals, Inc. | 606.11M |
| Palatin Technologies, Inc. | 14.40M |
| Theriva Biologics, Inc. | 6.468M |
Market Cap Related Metrics
| Price to Book Value | 0.5188 |
| Price | 0.5575 |
| Earnings Yield | -8.29K% |